From The Economic Times · Reuters · · 40s
TL;DR: Aragen Life Sciences IPO Plans $160.5m Expansion
Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut.
Aragen Life Sciences will invest Rs 15 billion over three years to expand its drug development and manufacturing capacity before its IPO. Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut. Aragen Life Sciences plans to spend Rs 15 billion over three years for expansion.
- IPO-bound Aragen expansion plans
- Investment breakdown
- Capacity expansion targets
Read the story version — the same reporting as a swipeable deck of 3 cards.



